ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026
ICP DAS-BMP is set to showcase its advanced medical-grade thermoplastic polyurethane (TPU) portfolio at the Medical Manufacturing Asia 2026 exhibition in Singapore. The company will highlight new low-migration and low-friction innovations designed for invasive medical devices.
Why it matters
Advancements in medical-grade materials are critical for the safety and efficacy of long-term implantable and invasive medical devices.
HSINCHU , Aug. 25, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), will exhibit at Medical Manufacturing Asia 2026, taking place September 9–11 at the Marina Bay Sands Expo & Convention Centre in Singapore (Booth 2U20 ) . Exhibiting together with its manufacturing partner, Towards Buddha Co., Ltd., the company will showcase its comprehensive medical TPU portfolio while also introducing integrated medical tubing extrusion and contract manufacturing (OEM/ODM) services for medical device manufacturers.
The spotlight will be on two TPU innovations addressing critical needs in medical device manufacturing: the Low-Migration Series and the Low-Friction Series.
The Low-Migration Arothane™ ARP-B20 TPU complies with ISO 10993 and is suitable for implantation up to 90 days. Its unique formulation minimizes additive migration to the surface of processed medical devices, helping maintain long-term stability.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in